ストックスクリーナーアプリを入手
35.06
0.11%
-0.04
アフターアワーズ：
35.08
0.02
+0.06%
Sanara Medtech Inc (SMTI) 最新ニュース
Sanara MedTech stock reports 9 percent revenue growth - AD HOC NEWS
Sanara MedTech (SMTI) Short Interest & Short Float | Updated Sep 2026 - MarketBeat
Precision Trading with Sanara Medtech Inc. (SMTI) Risk Zones - Stock Traders Daily
SMTI - Finviz
Sanara MedTech stock holds near its 52-week high - AD HOC NEWS
Sanara MedTech CEO Yon Seth D Forfeits 3,661 Shares at $35.11 Each - Kalkine Media
Sanara Medtech Inc (SMTI) Key Financial Ratios – Valuation, Profitability & More - Value Research
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc.SMTI - Business Wire
MIMEDX to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx - The Globe and Mail
[DEFM14A] Sanara MedTech Inc. Merger Proxy Statement - stocktitan.net
Why (SMTI) Price Action Is Critical for Tactical Trading - Stock Traders Daily
SMTI Q2 2026 Earnings: Wider-Than-Expected Loss Highlights Cost PressurePost-Announcement Reaction - dars.gov.et
Sanara MedTech (SMTI) Holds Steady at $34.57 as Traders Eye Resistance at $36.30ATR Trailing Stop - dars.gov.et
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanar - The National Law Review
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders - The Daily Tribune News
SMTI | Sanara MedTech Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc.SMTI - Eastern Progress
Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close - Stock Titan
Sanara MedTech Inc. (NASDAQ:SMTI) Short Interest Update - MarketBeat
Walleye Capital LLC Makes New $719,000 Investment in Sanara MedTech Inc. $SMTI - MarketBeat
SMTI Q1 2026 Earnings: Positive EPS Surprise Overcomes Expected LossOne-Time Gain Impact - vinanet.vn
Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny - Sahm
(SMTI) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) - The Manila Times
Sanara Medtech earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada
Sanara Medtech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates - Yahoo Finance
Sanara MedTech (NASDAQ:SMTI) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Sanara MedTech Q2 Results: Sales Rise 9% YoY, EPS Misses Estimate - scanx.trade
Sanara MedTech Inc. Q2 2026: Revenue $28.14M, EPS $(0.05) — 10-Q Summary - TradingView
Sanara MedTech (SMTI) grows H1 2026 revenue to $55.9M and trims loss - Stock Titan
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Form 8K Sanara Medtech Inc For: 11 August By Investing.com - Investing.com Nigeria
Sanara MedTech Corrects Termination Fees in Merger Deal with MiMedx - Kalkine Media
Sanara MedTech Inc. (SMTI) Releases Q2 2026 Earnings: Revenue Rises 8.9% - Quiver Quantitative
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
Sanara MedTech Q2 revenue rises on soft-tissue product growth - TradingView
Sanara MedTech (SMTI) grows revenue, posts Q2 loss amid pending MIMEDX deal - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review
Sanara Medtech Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTec - The National Law Review
Sanara MedTech (SMTI) Expected to Post Earnings on Wednesday - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc - The National Law Review
Sanara MedTech (NASDAQ:SMTI) Stock Rating Lowered by Freedom Capital - MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
How (SMTI) Movements Inform Risk Allocation Models - Stock Traders Daily
Sanara MedTech (SMTI) Holds Near $33.86 as Support Levels Come into FocusRSI Oversold Picks - siam.in
SANARA MEDTECH INC : H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $35 FROM $36 - webull.com
Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com
Is There Now An Opportunity In Sanara MedTech Inc. (NASDAQ:SMTI)? - webull.com
MiMedx to Buy Sanara MedTech for $350M - Medical Product Outsourcing
Sanara MedTech (SMTI) agrees to $350 million cash‑and‑stock acquisition by MiMedx - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK) - GlobeNewswire
MIMEDX To Acquire Sanara MedTech In $350 Million Transaction - Pulse 2.0
0.00%
0.51%
大文字化:
|
ボリューム (24 時間):